Barlow Carrolee sold SUPN
February 24, 2026 · Form 4 insider transaction
Barlow Carrolee sold 4,475 shares of Supernus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
4,475
Price
$0.00
Total value
N/A
InsiderBarlow Carrolee
Role—
SecurityRestricted Stock Unit
Transaction codeD: Disposition to the issuer
Transaction dateFebruary 24, 2026
Filing dateFebruary 25, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.; These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026.